vs
Jefferson Capital, Inc.（JCAP）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Jefferson Capital, Inc.的1.5倍（$219.9M vs $150.8M），Jefferson Capital, Inc.净利率更高（25.4% vs -1.0%，领先26.4%），Jefferson Capital, Inc.自由现金流更多（$63.0M vs $16.8M）
GE金融曾是通用电气旗下的金融服务分支，2013年至2021年间，其旗下多个业务单元陆续被出售，其中北美消费金融业务分拆为 Synchrony Financial 最为知名，最终仅保留GE能源金融服务部门，通用电气拆分后该部门被划归GE Vernova。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
JCAP vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.5倍
$150.8M
净利率更高
JCAP
高出26.4%
-1.0%
自由现金流更多
JCAP
多$46.2M
$16.8M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $150.8M | $219.9M |
| 净利润 | $38.4M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 46.4% | 0.2% |
| 净利率 | 25.4% | -1.0% |
| 营收同比 | — | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | $0.59 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JCAPOFIX
| Q4 25 | — | $219.9M | ||
| Q3 25 | $150.8M | $205.6M | ||
| Q2 25 | $152.7M | $203.1M | ||
| Q1 25 | — | $193.6M | ||
| Q4 24 | — | $215.7M | ||
| Q3 24 | — | $196.6M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $188.6M |
净利润JCAPOFIX
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $38.4M | $-22.8M | ||
| Q2 25 | $47.7M | $-14.1M | ||
| Q1 25 | — | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | — | $-27.4M | ||
| Q2 24 | — | $-33.4M | ||
| Q1 24 | — | $-36.0M |
毛利率JCAPOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率JCAPOFIX
| Q4 25 | — | 0.2% | ||
| Q3 25 | 46.4% | -8.3% | ||
| Q2 25 | 56.7% | -7.9% | ||
| Q1 25 | — | -25.2% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | — | -9.6% | ||
| Q2 24 | — | -12.5% | ||
| Q1 24 | — | -15.6% |
净利率JCAPOFIX
| Q4 25 | — | -1.0% | ||
| Q3 25 | 25.4% | -11.1% | ||
| Q2 25 | 31.2% | -6.9% | ||
| Q1 25 | — | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | — | -13.9% | ||
| Q2 24 | — | -16.8% | ||
| Q1 24 | — | -19.1% |
每股收益（稀释后）JCAPOFIX
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $0.59 | $-0.57 | ||
| Q2 25 | $16.76 | $-0.36 | ||
| Q1 25 | — | $-1.35 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | — | $-0.71 | ||
| Q2 24 | — | $-0.88 | ||
| Q1 24 | — | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.3M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $437.4M | $450.0M |
| 总资产 | $1.8B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资JCAPOFIX
| Q4 25 | — | $82.0M | ||
| Q3 25 | $42.3M | $62.9M | ||
| Q2 25 | $51.7M | $65.6M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $26.4M | ||
| Q1 24 | — | $27.0M |
总债务JCAPOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益JCAPOFIX
| Q4 25 | — | $450.0M | ||
| Q3 25 | $437.4M | $442.5M | ||
| Q2 25 | $410.8M | $458.3M | ||
| Q1 25 | — | $458.3M | ||
| Q4 24 | — | $503.1M | ||
| Q3 24 | — | $525.9M | ||
| Q2 24 | — | $546.0M | ||
| Q1 24 | — | $570.3M |
总资产JCAPOFIX
| Q4 25 | — | $850.6M | ||
| Q3 25 | $1.8B | $832.6M | ||
| Q2 25 | $1.8B | $837.2M | ||
| Q1 25 | — | $823.1M | ||
| Q4 24 | — | $893.3M | ||
| Q3 24 | — | $867.9M | ||
| Q2 24 | — | $882.0M | ||
| Q1 24 | — | $906.0M |
负债/权益比JCAPOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $63.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 41.7% | 7.6% |
| 资本支出强度资本支出/营收 | 0.1% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流JCAPOFIX
| Q4 25 | — | $27.7M | ||
| Q3 25 | $63.1M | $12.4M | ||
| Q2 25 | $130.6M | $11.6M | ||
| Q1 25 | — | $-18.4M | ||
| Q4 24 | — | $23.7M | ||
| Q3 24 | — | $11.7M | ||
| Q2 24 | — | $9.0M | ||
| Q1 24 | — | $-18.6M |
自由现金流JCAPOFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | $63.0M | $2.5M | ||
| Q2 25 | $130.0M | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $-360.0K | ||
| Q1 24 | — | $-29.1M |
自由现金流率JCAPOFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | 41.7% | 1.2% | ||
| Q2 25 | 85.1% | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | -0.2% | ||
| Q1 24 | — | -15.4% |
资本支出强度JCAPOFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | 0.1% | 4.8% | ||
| Q2 25 | 0.4% | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 4.7% | ||
| Q1 24 | — | 5.6% |
现金转化率JCAPOFIX
| Q4 25 | — | — | ||
| Q3 25 | 1.64× | — | ||
| Q2 25 | 2.74× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JCAP
| United States Segment | $108.1M | 72% |
| Other | $35.8M | 24% |
| United Kingdom Segment | $6.9M | 5% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
